1.  1
    Norbert Steinkamp, Bert Gordijn, Ana Borovecki, Eugenijus Gefenas, Jozef Glasa, Marc Guerrier, Tom Meulenbergs, Joanna Różyńska & Anne Slowther (2007). Regulation of Healthcare Ethics Committees in Europe. Medicine, Health Care and Philosophy 10 (4):461-475.
    In this article, the question is discussed if and how Healthcare Ethics Committees (HECs) should be regulated. The paper consists of two parts. First, authors from eight EC member countries describe the status quo in their respective countries, and give reasons as to the form of regulation they consider most adequate. In the second part, the country reports are analysed. It is suggested that regulation of HECs should be central and weak. Central regulation is argued to be apt to improve (...)
    Direct download (3 more)  
    Export citation  
    My bibliography   2 citations  
  2.  16
    Joanna Różyńska & Marek Czarkowski (2007). Emergency Research Without Consent Under Polish Law. Science and Engineering Ethics 13 (3):337-350.
    Although Directive 2001/20/EC of the European Parliament and of Council of 4 April 2001 on the approximation of the laws regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use does not contain an exception for emergency situations, and requires the informed consent of a legal representative in all cases where research is conducted on legally competent individuals who are unable to give (...)
    Direct download (4 more)  
    Export citation  
    My bibliography   1 citation  
  3.  1
    Joanna Różyńska (2015). On the Alleged Right to Participate in High‐Risk Research. Bioethics 29 (7):451-461.
    Reigning regulatory frameworks for biomedical research impose on researchers and research ethics committees an obligation to protect research participants from risks that are unnecessary, disproportionate to potential research benefits, and non-minimized. Where the research has no potential to produce results of direct benefit to the subjects and the subjects are unable to give consent, these requirements are strengthened by an additional condition, that risks should not exceed a certain minimal threshold. In this article, I address the question of whether there (...)
    Direct download (4 more)  
    Export citation  
    My bibliography